MedTrace Logo

Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation

NCT04438395 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-05-06

No results posted yet for this study

Summary

This is a prospective, single center, non-randomized, open-label, single arm study in which we will gather data and physician input for the assessment and further development of the KODEX - EPD functions for assessing tissue pressure, tissue thickness, lesion transmurality.

Conditions

  • Atrial Fibrillation and Flutter

Interventions

DEVICE

Cardiac ablation via catheter

Cardiac ablation with a catheter to treat atrial flutter and/or atrial fibrillation

Sponsors & Collaborators

  • EPD Solutions, A Philips Company

    lead INDUSTRY

Principal Investigators

  • Larry Chinitz, MD · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-06-30
Completion
2022-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04438395 on ClinicalTrials.gov